Skip to content

Clinical trials

Phase 2 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Clear all

714 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
200121
200216
200326
200422
200537
200634
200733
200831
200929
201030
201127
201231
201328
201420
201532
201622
201722
201818
201918
202017
202121
202221
202319
202425
202524
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed367
Terminated130
Recruiting74
Unknown status47
Active, not recruiting38
Withdrawn31
Not yet recruiting18
Suspended6
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center74
Fred Hutchinson Cancer Center34
Memorial Sloan Kettering Cancer Center29
Masonic Cancer Center, University of Minnesota23
National Heart, Lung, and Blood Institute (NHLBI)17
City of Hope Medical Center16
Groupe Francophone des Myelodysplasies16
National Cancer Institute (NCI)15
Novartis Pharmaceuticals15
Case Comprehensive Cancer Center13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes714
Leukemia, Myeloid, Acute345
Leukemia222
Precursor Cell Lymphoblastic Leukemia-Lymphoma180
Leukemia, Myelomonocytic, Chronic133
Myeloproliferative Disorders133
Lymphoma, Non-Hodgkin124
Leukemia, Lymphocytic, Chronic, B-Cell120
Hodgkin Disease115
Leukemia, Myelogenous, Chronic, BCR-ABL Positive108

Trials

Showing 51 to 75 of 714. Each trial links to its page on Pharma Observatory.

614 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.